16 July 2026 in Revista de Medicina Veterinaria
Platelet-derived products, such as autologous platelet concentrate (APCC) and platelet-rich fibrin (PRF), have generated significant medical interest due to their ability to regenerate hard and soft tissues. They are obtained from patients’ blood and have been used in various surgical specialties, including oral and maxillofacial surgery. Studies have evaluated their efficacy in musculoskeletal diseases and wounds, showing promising results in regeneration and healing. apcc is a preparation of autologous plasma with a high concentration of platelets and growth factors, obtained by centrifugation to remove red blood cells. prf, meanwhile, acts as a cellular scaffold that promotes cell migration and tissue healing, without the need for additives. In veterinary medicine, the application of apcc and prf has shown positive effects on the healing of bone and muscle defects in animal models. However, despite the encouraging results, their use is not fully accepted, as most studies have been conducted in small populations, and their applicability has yet to be evaluated on a large scale. Further research is needed to better understand their effects and ensure their safety and efficacy in different species and pathologies. This article compiles recent studies in animal models on the use of APCC and PRF in veterinary medicine, highlighting their positive effects on the healing of bone, muscle, and other injuries.